Nxera Pharma to Receive $35 Million Milestone Payment from Neurocrine Following Successful Phase 2 Schizophrenia Trial

Nxera Pharma Co – formerly known as Sosei Group or Sosei Heptares – announces that it will receive a US$35 million payment from Neurocrine Bi...

September 03, 2024 | Tuesday | News
Guardant Health Japan Receives MHLW Approval for First Blood-Based Diagnostic Test for EGFR Exon 20 Insertion Mutations in NSCLC

Guardant Health Japan Corp. (HQ: Minato-ku, Tokyo/ Representative Director: Mika Takaki), a leading precision oncology company, announced that the M...

September 03, 2024 | Tuesday | News
Thermo Fisher Scientific Expands Operations in the Philippines with New Global Business Services Center in Manila

  Thermo Fisher Scientific, the world leader in serving science, has announced the opening of a new Global Business Services Center (GBSC) in the P...

September 02, 2024 | Monday | News
HUTCHMED Voluntarily Withdraws Supplemental NDA for Fruquintinib in China, Cites Need for Further Evaluation in Gastric Cancer Treatment

HUTCHMED announces that it has voluntarily withdrawn its supplemental New Drug Application (“NDA”) in China for fruquintinib in combination w...

August 30, 2024 | Friday | News
GSK's Nucala Becomes First and Only Biologic Approved in Japan for CRSwNP with Four-Weekly Dosing Schedule

Nucala is the first and only biologic in Japan with a four-weekly dosing schedule for this condition Chronic rhinosinusitis with nasal polyps (CRSwNP)...

August 29, 2024 | Thursday | News
BioNexus Gene Lab Corp. Invests RM 1 Million in Malaysian Healthcare Tech Firm Ascension Innovation

BioNexus Gene Lab Corp. (NASDAQ: BGLC), an emerging leader in genomic diagnostics and health technology, today announced the successful closing of its RM...

August 27, 2024 | Tuesday | News
Fujitsu Launches Global Initiative to Attract Clinical Trials to Japan and Combat 'Drug Loss' with New Medical Data Ecosystem

Fujitsu announced that it will begin initiatives to attract global clinical trials to Japan and tackle the 'drug loss' issue by working with pharmaceutic...

August 27, 2024 | Tuesday | News
Honeywell Launches HQMR to Transform Quality Management in Life Sciences

Honeywell (NASDAQ: HON) has announced the launch of Honeywell Quality Management Review (HQMR), a new application designed to significantly improve ov...

August 26, 2024 | Monday | News
Varian Introduces HyperSight™ Imaging Extension to TrueBeam and Edge, Setting a New Standard in Asia Pacific Radiotherapy

HyperSight extension to TrueBeam and Edge offers one of the most advanced in-room imaging systems in Asia Pacific region HyperSight improves adaptive ...

August 26, 2024 | Monday | News
India's BioE3 Policy: A Strategic Leap Towards Global Biomanufacturing Leadership

Indian Union Cabinet, chaired by Prime Minister Shri Narendra Modi, recently approved the BioE3 (Biotechnology for Economy, Environment, and Empl...

August 26, 2024 | Monday | News
Basilea Pharmaceutica Earns $1.25M Milestone Payment as Cresemba® Sales Surge in Asia Pacific and China

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bac...

August 21, 2024 | Wednesday | News
QIAGEN Singapore Partners with Parkway Group to Enhance Patient Care through Advanced Syndromic Testing

Collaboration to improve patient care and epidemiological monitoring in Parkway Group's  private hospitals  QIAstat-Dx syndromic testing to pr...

August 20, 2024 | Tuesday | News
Amgen Selects Hyderabad for Its First India Center, Solidifying Telangana's Status as a Global Life Sciences Hub

Amgen, one of the world’s leading biotech companies, has announced the establishment of its first center in India, located in Hyderabad. After an e...

August 16, 2024 | Friday | News
Eisai and Biogen Announce Middle East Approval of Alzheimer’s Drug LEQEMBI® (lecanemab) in the UAE

Eisai Co., Ltd. and Biogen Inc. are pleased to announce that the Ministry of Health and Prevention in the United Arab Emirates (UAE) has approved the hum...

August 15, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close